Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-15

FDA Approved: OSMITROL — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Osmitrol (mannitol) submitted by Baxter Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OSMITROL (mannitol)

Snippet

SUPPL AP for OSMITROL (MANNITOL)